Benjamin Hamilton

5PUBLICATIONS
32CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Disease surveillanceCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2023
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease.

Neil Chanchlani, Simeng Lin, Rebecca Smith

|Aug 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.

Neil Chanchlani, Simeng Lin, Marcus K Auth

|Oct 29, 2021
Incidence and prevalence of inflammatory bowel disease in Devon, UK.

Ben Hamilton, Harry Green, Neel Heerasing

|Apr 27, 2021
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.

Nicholas A Kennedy, Simeng Lin, James R Goodhand

|Nov 07, 2020
Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.

Claire Gordon, Desmond Chee, Ben Hamilton

Pageof 1

Frequent Collaborators

5 joint publications

Neil Chanchlani

5 joint publications

Nicholas A Kennedy

5 joint publications

James R Goodhand

5 joint publications

Tariq Ahmad